claim: university of miami leads groundbreaking trial for covid-19 treatment.
evidence_1: university of miami miller school of medicine researchers led a unique and groundbreaking randomized controlled trial showing umbilical-cord derived mesenchymal stem cell infusions safely reduce risk of death and quicken time to recovery for the severest covid-19 patients, according to results published in stem cells translational medicine on january 5.", "the study's senior author, camillo ricordi, m.d., director of the diabetes research institute (dri) and cell transplant center at the university of miami miller school of medicine, said treating covid-19 with mesenchymal stem cells makes sense.", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "the studys senior author, camillo ricordi, m.d., director of the diabetes research institute (dri) and cell transplant center at the university of miami miller school of medicine, said treating covid-19 with mesenchymal stem cells makes sense.")